Xenon Pharmaceuticals (XENE) Expert Call Strengthens Expectation Conviction on Peak Sales - Jefferies
Tweet Send to a Friend
Jefferies analyst Andrew Tsai reiterated a Buy rating and $50.00 price target on Xenon Pharmaceuticals (NASDAQ: XENE) after hosting a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
